Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
10 03 2022
Historique:
pubmed: 26 2 2022
medline: 19 4 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Aldehyde dehydrogenases (ALDHs) are overexpressed in various tumor types including prostate cancer and considered a potential target for therapeutic intervention. 4-(Diethylamino)benzaldehyde (DEAB) has been extensively reported as a pan-inhibitor of ALDH isoforms, and here, we report on the synthesis, ALDH isoform selectivity, and cellular potencies in prostate cancer cells of 40 DEAB analogues; three analogues (

Identifiants

pubmed: 35212533
doi: 10.1021/acs.jmedchem.1c01367
pmc: PMC9007462
doi:

Substances chimiques

Benzaldehydes 0
4-(diethylamino)benzaldehyde 120-21-8
Aldehyde Dehydrogenase EC 1.2.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3833-3848

Subventions

Organisme : Prostate Cancer UK
ID : S12-027
Pays : United Kingdom

Références

Clin Cancer Res. 2013 Mar 15;19(6):1512-24
pubmed: 23340294
Br J Cancer. 2014 May 13;110(10):2593-603
pubmed: 24762960
Ther Adv Urol. 2014 Jun;6(3):97-104
pubmed: 24883107
Chem Biol Interact. 2015 Jun 5;234:18-28
pubmed: 25512087
Hum Genomics. 2011 May;5(4):283-303
pubmed: 21712190
Free Radic Biol Med. 2012 Feb 15;52(4):735-46
pubmed: 22206977
Biochim Biophys Acta. 2009 Dec;1787(12):1433-43
pubmed: 19524545
Arch Biochem Biophys. 2020 Mar 15;681:108256
pubmed: 31923393
Reprod Domest Anim. 2016 Dec;51(6):901-909
pubmed: 27569851
Cancer Treat Rev. 2016 Sep;49:25-36
pubmed: 27434881
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11707-12
pubmed: 16857736
Oncotarget. 2015 Dec 29;6(42):44191-206
pubmed: 26496035
Chem Biol Interact. 2012 Jan 5;195(1):52-60
pubmed: 22079344
Drugs. 2018 Dec;78(18):1913-1924
pubmed: 30535926
Clin Exp Metastasis. 2011 Oct;28(7):615-25
pubmed: 21647815
Stem Cells. 2011 Jan;29(1):32-45
pubmed: 21280157
Methods Mol Biol. 2016;1443:181-201
pubmed: 27246341
Org Biomol Chem. 2011 Dec 7;9(23):7979-82
pubmed: 21946911
Methods Biochem Anal. 2005;46:1-265
pubmed: 16350889
Cell Cycle. 2011 May 1;10(9):1378-84
pubmed: 21552008
Stem Cell Rev Rep. 2011 Jun;7(2):292-306
pubmed: 21103958
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Breast Cancer Res Treat. 2012 May;133(1):75-87
pubmed: 21818590
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Cancer Res. 2015 Apr 1;75(7):1482-94
pubmed: 25670168
ACS Chem Biol. 2015 Mar 20;10(3):693-7
pubmed: 25554827
Nat Clin Pract Urol. 2009 Feb;6(2):76-85
pubmed: 19198621
J Med Chem. 2014 Jan 23;57(2):449-61
pubmed: 24387105
Cancer Res. 2010 Jun 15;70(12):5163-73
pubmed: 20516116
Nucleic Acids Res. 2012 Jun;40(11):4825-40
pubmed: 22362749
Exp Ther Med. 2020 Jul;20(1):662-670
pubmed: 32550888
Oncotarget. 2018 Apr 27;9(32):22703-22716
pubmed: 29854309
Cell Biol Toxicol. 2019 Apr;35(2):161-177
pubmed: 30220009
Nature. 2012 Jul 12;487(7406):239-43
pubmed: 22722839
Oncotarget. 2015 Mar 10;6(7):5324-41
pubmed: 25481874
J Clin Oncol. 2008 Jun 10;26(17):2862-70
pubmed: 18539965
Clin Cancer Res. 2009 Jun 15;15(12):4234-41
pubmed: 19509181
Cytometry B Clin Cytom. 2007 Jul;72(4):281-9
pubmed: 17111384
Oncotarget. 2017 Jul 25;8(59):99382-99393
pubmed: 29245909
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8644-9
pubmed: 23650391
Biomedicines. 2020 Dec 04;8(12):
pubmed: 33291762
BMC Cancer. 2020 May 6;20(1):387
pubmed: 32375698
Cancer J. 2016 Sep/Oct;22(5):330-333
pubmed: 27749326
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
Clin Cancer Res. 2013 Oct 1;19(19):5361-71
pubmed: 23969936
Mol Oncol. 2014 Feb;8(1):142-9
pubmed: 24210755
Br J Cancer. 2015 Apr 28;112(9):1536-45
pubmed: 25839988
Stem Cell Reports. 2019 Oct 8;13(4):730-746
pubmed: 31564647
Biochem Pharmacol. 1995 Jul 31;50(3):399-406
pubmed: 7646541
Oncotarget. 2016 Mar 8;7(10):11018-32
pubmed: 26783961
Sci Rep. 2016 Oct 19;6:35710
pubmed: 27759097
J Med Chem. 2015 Feb 26;58(4):1964-75
pubmed: 25634381
Cell Cycle. 2009 Oct 15;8(20):3297-302
pubmed: 19806016
J Chem Inf Model. 2014 Oct 27;54(10):2980-6
pubmed: 25211541
PLoS One. 2010 Nov 11;5(11):e13943
pubmed: 21085683
Lab Invest. 2010 Feb;90(2):234-44
pubmed: 20010854
Drug Discov Today. 2014 Dec;19(12):1953-63
pubmed: 25256776
Chem Biol Interact. 2019 Jun 1;306:123-130
pubmed: 30958995
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866

Auteurs

Ali I M Ibrahim (AIM)

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Yorkshire BD7 1DP, U.K.
Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.

Elisabet Batlle (E)

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Yorkshire BD7 1DP, U.K.
Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Smarakan Sneha (S)

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Yorkshire BD7 1DP, U.K.

Rafael Jiménez (R)

Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Raquel Pequerul (R)

Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Xavier Parés (X)

Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Till Rüngeler (T)

Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Vibhu Jha (V)

Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.

Tiziano Tuccinardi (T)

Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.

Maria Sadiq (M)

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Yorkshire BD7 1DP, U.K.
Cancer Research Unit, Department of Biology, University of York, Heslington, Yorkshire YO10 5DD, U.K.

Fiona Frame (F)

Cancer Research Unit, Department of Biology, University of York, Heslington, Yorkshire YO10 5DD, U.K.

Norman J Maitland (NJ)

Cancer Research Unit, Department of Biology, University of York, Heslington, Yorkshire YO10 5DD, U.K.

Jaume Farrés (J)

Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Bellaterra, Barcelona E-08193, Spain.

Klaus Pors (K)

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Yorkshire BD7 1DP, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH